Trexquant Investment LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $41,536 - $51,219	2,356 Added 3.29%	73,906 $1.46 Million
Q4 2023 Feb 09, 2024	SELL	$14.37 - $19.07 $75,773 - $100,556	-5,273 Reduced 6.86%	71,550 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$13.62 - $20.2 $126,298 - $187,314	-9,273 Reduced 10.77%	76,823 $1.33 Million
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $479,175 - $756,399	45,898 Added 114.18%	86,096 $1.21 Million
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $269,468 - $397,655	-25,184 Reduced 38.52%	40,198 $432,000
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $97,892 - $146,152	8,572 Added 15.09%	65,382 $979,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $554,465 - $761,822	56,810 New	56,810 $729,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $760M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.